Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
The SuperPatch Company
- License Information
-
More Information
Article History
Received: 17 July 2025
Accepted: 18 September 2025
First Online: 8 October 2025
Declarations
:
: Janet Fason, DO, was compensated for her role as Principal Investigator of this study. Jeffrey Gudin, MD, was compensated for his role as an investigator on this study. Peter Hurwitz is President of Clarity Science, LLC, the clinical research organization (CRO) that was compensated for the administration of the study.
: All research subject data collection for this study was completed as of March 2025. This study involving human participants was reviewed and approved by Advarra, the Institutional Review Board (IRB) of record. The study protocol was conducted in accordance with the ethical standards of the institutional and national research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All patients provided written informed consent to participate in this study and for the use of outcome measures.
